Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Breast Cancer

  Free Subscription


29.04.2019

1 Ann Surg Oncol
2 Anticancer Res
6 BMC Cancer
9 Breast Cancer Res Treat
4 Breast J
2 Cancer
2 Cancer Epidemiol Biomarkers Prev
1 Cancer Lett
1 Cancer Res
2 Clin Cancer Res
1 Histopathology
4 Int J Cancer
1 Lancet Oncol
4 PLoS One
3 Radiother Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Surg Oncol

  1. BEAR HD, McGuire KP
    Sentinel Node Biopsy After Neoadjuvant Systemic Therapy for Breast Cancer: The Method Matters.
    Ann Surg Oncol. 2019 Apr 24. pii: 10.1245/s10434-019-07401.
    PubMed     Text format    


    Anticancer Res

  2. PINELLI A, Ferrario P, Trivulzio S
    Preliminary Observation on the Cytotoxic Activity of New Chlorophyllin Derivative RCD on Human Tumour Cell Lines In Vitro.
    Anticancer Res. 2019;39:1807-1812.
    PubMed     Text format     Abstract available

  3. GKANTAIFI A, Papadopoulos C, Spyropoulou D, Toumpourleka M, et al
    Breast Radiotherapy and Early Adverse Cardiac Effects. The Role of Serum Biomarkers and Strain Echocardiography.
    Anticancer Res. 2019;39:1667-1673.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. DERESSA BT, Cihoric N, Badra EV, Tsikkinis A, et al
    Breast cancer care in northern Ethiopia - cross-sectional analysis.
    BMC Cancer. 2019;19:393.
    PubMed     Text format     Abstract available

  5. LU L, Huang H, Zhou J, Ma W, et al
    BRCA1 mRNA expression modifies the effect of T cell activation score on patient survival in breast cancer.
    BMC Cancer. 2019;19:387.
    PubMed     Text format     Abstract available

  6. SALERNO EA, Rowland K, Kramer AF, McAuley E, et al
    Acute aerobic exercise effects on cognitive function in breast cancer survivors: a randomized crossover trial.
    BMC Cancer. 2019;19:371.
    PubMed     Text format     Abstract available

  7. HOUVENAEGHEL G, Lambaudie E, Classe JM, Mazouni C, et al
    Lymph node positivity in different early breast carcinoma phenotypes: a predictive model.
    BMC Cancer. 2019;19:45.
    PubMed     Text format     Abstract available

  8. ZHAO Y, Luo H, Zhang X, Bianba T, et al
    Clinicopathological characteristics and health care for Tibetan women with breast cancer: a cross-sectional survey.
    BMC Cancer. 2019;19:380.
    PubMed     Text format     Abstract available

  9. LEE J, Lee EH, Park HY, Kim WW, et al
    Efficacy of an RNA-based multigene assay with core needle biopsy samples for risk evaluation in hormone-positive early breast cancer.
    BMC Cancer. 2019;19:388.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  10. GAO C, Yuan X, Jiang Z, Gan D, et al
    Regulation of AKT phosphorylation by GSK3beta and PTEN to control chemoresistance in breast cancer.
    Breast Cancer Res Treat. 2019 Apr 20. pii: 10.1007/s10549-019-05239.
    PubMed     Text format     Abstract available

  11. SAMBADE MJ, Prince G, Deal AM, Trembath D, et al
    Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases.
    Breast Cancer Res Treat. 2019 Apr 23. pii: 10.1007/s10549-019-05211.
    PubMed     Text format     Abstract available

  12. ALTUNDAG K
    Oral or intravenous vinorelbine plus capecitabine in heavily pretreated HER2 negative metastatic breast cancer; similar effect or quality of life?
    Breast Cancer Res Treat. 2019 Apr 23. pii: 10.1007/s10549-019-05220.
    PubMed     Text format    

  13. WANG M, Chen H, Wu K, Ding A, et al
    Post-mastectomy immediate breast reconstruction is oncologically safe in well-selected T4 locally advanced breast cancer: a large population-based study and matched case-control analysis.
    Breast Cancer Res Treat. 2019 Apr 24. pii: 10.1007/s10549-019-05240.
    PubMed     Text format     Abstract available

  14. LEE HM, Kim BW, Park S, Park S, et al
    Childbirth in young Korean women with previously treated breast cancer: The SMARTSHIP study.
    Breast Cancer Res Treat. 2019 Apr 24. pii: 10.1007/s10549-019-05244.
    PubMed     Text format     Abstract available

  15. SCHAIRER C, Hablas A, Eldein IAS, Gaafar R, et al
    Clinico-pathologic and mammographic characteristics of inflammatory and non-inflammatory breast cancer at six centers in North Africa.
    Breast Cancer Res Treat. 2019 Apr 22. pii: 10.1007/s10549-019-05237.
    PubMed     Text format     Abstract available

  16. ABU-KHALAF MM, Safonov A, Stratton J, Wang S, et al
    Examining the cost-effectiveness of baseline left ventricular function assessment among breast cancer patients undergoing anthracycline-based therapy.
    Breast Cancer Res Treat. 2019 Apr 24. pii: 10.1007/s10549-019-05178.
    PubMed     Text format     Abstract available

  17. BAHRI N, Fathi Najafi T, Homaei Shandiz F, Tohidinik HR, et al
    The relation between stressful life events and breast cancer: a systematic review and meta-analysis of cohort studies.
    Breast Cancer Res Treat. 2019 Apr 19. pii: 10.1007/s10549-019-05231.
    PubMed     Text format     Abstract available

  18. BELLON JR, Guo H, Barry WT, Dang CT, et al
    Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial).
    Breast Cancer Res Treat. 2019 Apr 19. pii: 10.1007/s10549-019-05238.
    PubMed     Text format     Abstract available


    Breast J

  19. DUBROVSKY E, Raymond S, Chun J, Fong A, et al
    Genomic testing in early stage invasive male breast cancer: An NCDB analysis from 2008 to 2014.
    Breast J. 2019;25:425-433.
    PubMed     Text format     Abstract available

  20. SHREENIVAS A, Shapiro CL
    Central nervous system metastases in triple-negative breast cancer: A step in the right direction.
    Breast J. 2019;25:361-362.
    PubMed     Text format    

  21. AMRO A, Chen Y, Barry R, Susick L, et al
    Distribution and Short-term Prognostic Value of the 21-gene recurrence score in African American compared to White American breast cancer patients.
    Breast J. 2019 Apr 25. doi: 10.1111/tbj.13256.
    PubMed     Text format     Abstract available

  22. LUBIAN LOPEZ DM, Castillo Lara M, Rodriguez Rodriguez B, Butron Hinojo CA, et al
    Metabolic syndrome and prognostic factors in postmenopausal breast cancer patients.
    Breast J. 2019;25:548-551.
    PubMed     Text format    


    Cancer

  23. LYNCH BM, Nguyen NH, Moore MM, Reeves MM, et al
    A randomized controlled trial of a wearable technology-based intervention for increasing moderate to vigorous physical activity and reducing sedentary behavior in breast cancer survivors: The ACTIVATE Trial.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32143.
    PubMed     Text format     Abstract available

  24. HAWKINS BRESSLER L, Mersereau JE, Anderson C, Rodriguez JL, et al
    Fertility-related experiences after breast cancer diagnosis in the Sister and Two Sister Studies.
    Cancer. 2019 Apr 23. doi: 10.1002/cncr.32126.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  25. GLYNN RJ, Colditz GA, Tamimi RM, Chen WY, et al
    Comparison of questionnaire-based breast cancer prediction models in the Nurses' Health Study.
    Cancer Epidemiol Biomarkers Prev. 2019 Apr 23. pii: 1055-9965.EPI-18-1039.
    PubMed     Text format     Abstract available

  26. VISSER LL, Groen EJ, van Leeuwen FE, Lips EH, et al
    Predictors of an Invasive Breast Cancer Recurrence after DCIS: A Systematic Review and Meta-analyses.
    Cancer Epidemiol Biomarkers Prev. 2019 Apr 25. pii: 1055-9965.EPI-18-0976.
    PubMed     Text format     Abstract available


    Cancer Lett

  27. SON D, Kim Y, Lim S, Kang HG, et al
    miR-374a-5p promotes tumor progression by targeting ARRB1 in triple negative breast cancer.
    Cancer Lett. 2019;454:224-233.
    PubMed     Text format     Abstract available


    Cancer Res

  28. LIU LM, Sun WZ, Fan XZ, Xu YL, et al
    Methylation of C/EBPalpha by PRMT1 inhibits its tumor suppressive function in breast cancer.
    Cancer Res. 2019 Apr 23. pii: 0008-5472.CAN-18-3211.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  29. LIGIBEL J, Dillon DA, Giobbie-Hurder A, McTiernan A, et al
    Impact of a pre-operative exercise intervention on breast cancer proliferation and gene expression: Results from the Pre-Operative Health and Body (PreHAB) Study.
    Clin Cancer Res. 2019 Apr 24. pii: 1078-0432.CCR-18-3143.
    PubMed     Text format     Abstract available

  30. ZHANG J, Chen J, Wo D, Yan H, et al
    LRP6 ectodomain prevents SDF-1/CXCR4-induced breast cancer metastasis to lung.
    Clin Cancer Res. 2019 Apr 22. pii: 1078-0432.CCR-18-3557.
    PubMed     Text format     Abstract available


    Histopathology

  31. LEUNG SCY, Nielsen TO, Zabaglo LA, Arun I, et al
    Analytical validation of a standardized scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicenter collaboration.
    Histopathology. 2019 Apr 24. doi: 10.1111/his.13880.
    PubMed     Text format     Abstract available


    Int J Cancer

  32. FEKETE JT, Gyorffy B
    ROCplot.org: Validating predictive biomarkers of chemotherapy/hormonal therapy/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients.
    Int J Cancer. 2019 Apr 24. doi: 10.1002/ijc.32369.
    PubMed     Text format     Abstract available

  33. GE J, Liu H, Qian D, Wang X, et al
    Genetic variants of genes in the NER pathway associated with risk of breast cancer: a large-scale analysis of 14 published GWAS datasets in the DRIVE Study.
    Int J Cancer. 2019 Apr 26. doi: 10.1002/ijc.32371.
    PubMed     Text format     Abstract available

  34. WANG Z, Li Y, Xiao Y, Lin HP, et al
    Integrin alpha9 depletion promotes beta-catenin degradation to suppress triple negative breast cancer tumor growth and metastasis.
    Int J Cancer. 2019 Apr 22. doi: 10.1002/ijc.32359.
    PubMed     Text format     Abstract available

  35. MANCINI FR, Cano-Sancho G, Gambaretti J, Marchand P, et al
    Perfluorinated alkylated substances serum concentration and breast cancer risk: Evidence from a nested case-control study in the French E3N cohort.
    Int J Cancer. 2019 Apr 22. doi: 10.1002/ijc.32357.
    PubMed     Text format     Abstract available


    Lancet Oncol

  36. GOURD E
    Mammography deficiencies: the result of poor positioning.
    Lancet Oncol. 2018;19:e385.
    PubMed     Text format    


    PLoS One

  37. NOYAN S, Gurdal H, Gur Dedeoglu B
    Involvement of miR-770-5p in trastuzumab response in HER2 positive breast cancer cells.
    PLoS One. 2019;14:e0215894.
    PubMed     Text format     Abstract available

  38. LOI S, Michiels S, Baselga J, Bartlett JMS, et al
    Correction: PIK3CA Genotype and a PIK3CA Mutation-Related Gene Signature and Response to Everolimus and Letrozole in Estrogen Receptor Positive Breast Cancer.
    PLoS One. 2019;14:e0216175.
    PubMed     Text format     Abstract available

  39. WEN WX, Leong CO
    Association of BRCA1- and BRCA2-deficiency with mutation burden, expression of PD-L1/PD-1, immune infiltrates, and T cell-inflamed signature in breast cancer.
    PLoS One. 2019;14:e0215381.
    PubMed     Text format     Abstract available

  40. LYNG FM, Traynor D, Nguyen TNQ, Meade AD, et al
    Correction: Discrimination of breast cancer from benign tumours using Raman spectroscopy.
    PLoS One. 2019;14:e0216311.
    PubMed     Text format     Abstract available


    Radiother Oncol

  41. KALLIS K, Kaltsas T, Kreppner S, Lotter M, et al
    Impact of inter- and intra-observer variabilities of catheter reconstruction on multi-catheter interstitial brachytherapy of breast cancer patients.
    Radiother Oncol. 2019;135:25-32.
    PubMed     Text format     Abstract available

  42. STICK LB, Vogelius IR, Modiri A, Rice SR, et al
    Inverse radiotherapy planning based on bioeffect modelling for locally advanced left-sided breast cancer.
    Radiother Oncol. 2019;136:9-14.
    PubMed     Text format     Abstract available

  43. VAN DEN BOGAARD VAB, van Dijk LV, Vliegenthart R, Sijtsema NM, et al
    Development and evaluation of an auto-segmentation tool for the left anterior descending coronary artery of breast cancer patients based on anatomical landmarks.
    Radiother Oncol. 2019;136:15-20.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: